Patents by Inventor Arthur G. Schwartz

Arthur G. Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treatment of non-alcoholic steatohepatitis
    Patent number: 10226474
    Abstract: A method for the treatment of an individual suffering from non-alcoholic steatohepatitis is provided comprising administering to the individual in need of such treatment an effective amount of a compound according to Formula I: wherein: R1, R2, R4, R5, R6, and R7 are each individually hydrogen, hydroxyl, —(C1-C6)alkyl or —(C1-C6)alkoxy; each R3 is individually halogen, hydrogen, hydroxyl, —(C1-C6)alkyl or —(C1-C6)alkoxy; X is halogen, hydroxyl, hydrogen, —(C1-C6)alkyl or —(C1-C6)alkoxy; Z is hydrogen, —(C1-C6)alkyl or —(C1-C6)alkoxy, and n is 1 or 2.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: March 12, 2019
    Assignee: TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYTEM OF HIGHER EDUCATION
    Inventor: Arthur G. Schwartz
  • METHODS AND COMPOSITIONS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
    Publication number: 20180193356
    Abstract: A method for the treatment of an individual suffering from non-alcoholic steatohepatitis is provided comprising administering to the individual in need of such treatment an effective amount of a compound according to Formula I: wherein: R1, R2, R4, R5, R6, and R7 are each individually hydrogen, hydroxyl, —(C1-C6)alkyl or —(C1-C6)alkoxy; each R3 is individually halogen, hydrogen, hydroxyl, —(C1-C6)alkyl or —(C1-C6)alkoxy; X is halogen, hydroxyl, hydrogen, —(C1-C6)alkyl or —(C1-C6)alkoxy; Z is hydrogen, —(C1-C6)alkyl or —(C1-C6)alkoxy, and n is 1 or 2.
    Type: Application
    Filed: January 9, 2018
    Publication date: July 12, 2018
    Inventor: Arthur G. Schwartz
  • Topical steroidal formulations
    Patent number: 9408856
    Abstract: The present invention relates to formulations of poorly water soluble pharmaceutical agents of Formula I and II. The present invention also relates to compositions containing compounds of Formula I or II, and glucocorticoids, and methods for reducing side effects from glucocorticoid treatment by co-administration of compounds of Formula I and II. The compositions herein are useful for the treatment of diabetes and obesity related diseases including metabolic syndrome.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: August 9, 2016
    Assignee: TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Arthur G Schwartz, John R Williams
  • Topical steroidal formulations
    Patent number: 9402853
    Abstract: The present invention relates to formulations of poorly water soluble pharmaceutical agents of Formula I and II. The present invention also relates to compositions containing compounds of Formula I or II, and glucocorticoids, and methods for reducing side effects from glucocorticoid treatment by co-administration of compounds of Formula I and II. The compositions herein are useful for the treatment of diabetes and obesity related diseases including metabolic syndrome.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: August 2, 2016
    Assignee: TEMPLE UNIVERSITY-OF THE COMMONWEALTH OF HIGHER EDUCATION
    Inventors: Arthur G Schwartz, John R Williams
  • Topical steroidal formulations
    Patent number: 8431555
    Abstract: The present invention relates to formulations of poorly water soluble pharmaceutical agents of Formula I and II. The present invention also relates to compositions containing compounds of Formula I or II, and glucocorticoids, and methods for reducing side effects from glucocorticoid treatment by co-administration of compounds of Formula I and II. The compositions herein are useful for the treatment of diabetes and obesity related diseases including metabolic syndrome.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: April 30, 2013
    Assignee: Temple University—Of The Commonwealth System of Higher Education
    Inventors: Arthur G. Schwartz, John R. Williams
  • TOPICAL STEROIDAL FORMULATIONS
    Publication number: 20100004217
    Abstract: The present invention relates to formulations of poorly water soluble pharmaceutical agents of Formula I and II. The present invention also relates to compositions containing compounds of Formula I or II, and glucocorticoids, and methods for reducing side effects from glucocorticoid treatment by co-administration of compounds of Formula I and II. The compositions herein are useful for the treatment of diabetes and obesity related diseases including metabolic syndrome.
    Type: Application
    Filed: June 30, 2009
    Publication date: January 7, 2010
    Inventors: Arthur G. Schwartz, John R. Williams
  • 7-Hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof
    Publication number: 20040034003
    Abstract: The present invention relates to 7-hydroxy-16&agr;-fluoro-5-androsten-17-one and 7-hydroxy-16&agr;-fluoro-5-androstan-17-one derivatives and their use.
    Type: Application
    Filed: May 1, 2003
    Publication date: February 19, 2004
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Compounds useful for treating hypertriglyceridemia
    Publication number: 20040019026
    Abstract: The present invention is directed to a method for treating a patient having hypertriglyceridemia comprising administering thereto a compound of the formula: 1
    Type: Application
    Filed: April 7, 2003
    Publication date: January 29, 2004
    Inventor: Arthur G. Schwartz
  • Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
    Patent number: 5804576
    Abstract: Steroids of the formula: ##STR1## useful as cancer preventive agents, anti-obesity agents, anti-hyperglycemic agents, anti-aging agents, and anti-hypercholesterolemic agents and anti-auto-immune agents.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 8, 1998
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, John R. Williams, Magid Abou-Gharbia, Ann R. Swern, Marvin Louis Lewbart
  • Steroids useful as anti-cancer and anti-obesity agents
    Patent number: 5744462
    Abstract: Compounds of the formulae: ##STR1## useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agent.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 28, 1998
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, Marvin Louis Lewbart
  • Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
    Patent number: 5714481
    Abstract: Steroids of the formula: ##STR1## useful as cancer preventive agents, anti-obesity agents, anti-hyperglycemic agents, anti-aging agents, and anti-hypercholesterolemic agents and anti-auto-immune agents.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: February 3, 1998
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, John R. Williams, Magid Abou-Gharbia, Daniel Swern, deceased, Marvin Louis Lewbart
  • Steroids useful as anti-cancer and anti-obesity agents
    Patent number: 5700793
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 23, 1997
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, Marvin Louis Lewbart
  • Steroids useful as anti-cancer and anti-obesity agents
    Patent number: 5696106
    Abstract: The present invention is directed to compounds of the formula. ##STR1## useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agent.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 9, 1997
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, Marvin Louis Lewbart
  • Steroids useful as anti-cancer and anti-obesity agents
    Patent number: 5656621
    Type: Grant
    Filed: February 15, 1994
    Date of Patent: August 12, 1997
    Assignee: Research Corporation Tech., Inc.
    Inventors: Arthur G. Schwartz, Marvin Louis Lewbart
  • 5 .alpha.-pregnan-20-ones and 5-pregnen-20-ones and related compounds
    Patent number: 5175154
    Abstract: Compounds of the formulae: ##STR1## useful as anti-obesity, anti-diabetic, anti-coronary and hypolipidemic agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: December 29, 1992
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Method for prophylaxis of obesity
    Patent number: 5157031
    Type: Grant
    Filed: March 21, 1989
    Date of Patent: October 20, 1992
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Homoandrostan-17-one and homoandrosten-17-ones
    Patent number: 5028631
    Abstract: Compounds of the formula: ##STR1## useful as anti-cancer agents, anti-obesity agents, anti-hyperglycemic agents, anti-aging agents, anti-hyperglycemic agents and anti-autoimmune agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: July 2, 1991
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • 16-substituted androstanes and 16-substituted androstenes
    Patent number: 5001119
    Abstract: Compounds of the formula: ##STR1## are useful as anti-cancer, anti-obesity, anti-diabetic, anti-coronary agents, anti-aging agents, anti-hypolipidemic agents and anti-autoimmune agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: March 19, 1991
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • 17-Hydroxy-steroids
    Patent number: 4898694
    Abstract: Compounds of the formulae: ##STR1## are useful as anti-cancer, anti-obesity, anti-diabetic, anti-coronary agents, anti-aging agents, anti-hypolipidemic agents and anti-autoimmune agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: February 6, 1990
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Long residence pollution control system
    Patent number: 4690697
    Abstract: Method and apparatus for removing noxious gases, such as, oxides of nitrogen, sulfur or carbon from industrial influent gas streams which utilizes growing plants positioned in long residence contact time apparatus for removing the noxious gases.
    Type: Grant
    Filed: February 20, 1986
    Date of Patent: September 1, 1987
    Inventors: Arthur G. Schwartz, Richard M. Gurries, Jay K. Johnson